Comparing Leflunomide vs Tofacitinib
Leflunomide | Tofacitinib |
|
---|
Leflunomide | Tofacitinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Rheumatoid Arthritis, Psoriatic Arthritis. Leflunomide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, Polyarticular Juvenile Idiopathic Arthritis. Tofacitinib may also be used for purposes not listed... View more |
Related suggestions Rheumatoid Arthritis
|
|||||||
More about Leflunomide | More about Tofacitinib | ||||||||
Ratings & Reviews | |||||||||
Leflunomide has an average rating of 5.1 out of 10 from a total of 115 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 46% reported a negative effect. |
Tofacitinib has an average rating of 5.7 out of 10 from a total of 173 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Leflunomide side effects |
View all Tofacitinib side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Leflunomide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Arava | Xeljanz, Xeljanz Oral Solution, Xeljanz XR | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
336 hours |
3 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 680 drugs are known to interact with Leflunomide:
|
A total of 660 drugs are known to interact with Tofacitinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
September 10, 1998 |
November 06, 2012 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Plaquenil
Plaquenil is used to treat or prevent malaria and to treat the symptoms of rheumatoid arthritis ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Arava
Arava (leflunomide) is used to treat the symptoms of rheumatoid arthritis and help reduce joint ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Orencia
Orencia is a type of biologic that is given by intravenous infusion or subcutaneous injection which ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.